Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Butler

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
The Psychiatric Clinics of North America|February 27, 2022
Emerging Knowledge of the Neurobiology of COVID-19Matthew Butler, Benjamin Cross, Danish Hafeez, et al.
Therapeutic Advances in Psychopharmacology|May 22, 2020
Psychedelic treatment of functional neurological disorder: a systematic reviewMatthew Butler, Mathieu Seynaeve, Timothy R Nicholson, et al.
Therapeutic Advances in Psychopharmacology|September 25, 2020
Clozapine prescribing in COVID-19 positive medical inpatients: a case seriesMatthew Butler, Felicity Bano, Marilia Calcia, et al.
IEEE Computer Graphics and Applications|March 17, 2021
The Next Billion Users of VisualizationAmit Jena, Matthew Butler, Tim Dwyer, et al.
Veterinary Journal (London, England : 1997)|June 2, 2022
The microvascular endothelial glycocalyx: An additional piece of the puzzle in veterinary medicineSara J Lawrence-Mills, David Hughes, Melanie J Hezzell, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|July 15, 2021
Functional Neurological Disorder After SARS-CoV-2 Vaccines: Two Case Reports and Discussion of Potential Public Health ImplicationsMatthew Butler, Jan Coebergh, Farinaz Safavi, et al.
Headache|April 5, 2021
Pharmacokinetics and safety of ubrogepant when coadministered with calcitonin gene-related peptide-targeted monoclonal antibody migraine preventives in participants with migraine: A randomized phase 1b drug-drug interaction studyAbhijeet Jakate, Andrew M Blumenfeld, Ramesh Boinpally, et al.
Headache|January 9, 2020
Long-Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52-Week Extension TrialJessica Ailani, Richard B Lipton, Susan Hutchinson, et al.
Frontiers in Psychiatry|February 19, 2021
Reduced Activity in an Inpatient Liaison Psychiatry Service During the First Wave of the COVID-19 Pandemic: Comparison With 2019 Data and Characterization of the SARS-CoV-2 Positive CohortMatthew Butler, Afraa Delvi, Fedza Mujic, et al.
Haematologica|September 28, 2019
Functional assessment of glucocerebrosidase modulator efficacy in primary patient-derived macrophages is essential for drug development and patient stratificationNatalie J Welsh, Christina A Gewinner, Kavita Mistry, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
The Psychiatric Clinics of North America|February 27, 2022
Emerging Knowledge of the Neurobiology of COVID-19Matthew Butler, Benjamin Cross, Danish Hafeez, et al.
Therapeutic Advances in Psychopharmacology|May 22, 2020
Psychedelic treatment of functional neurological disorder: a systematic reviewMatthew Butler, Mathieu Seynaeve, Timothy R Nicholson, et al.
Therapeutic Advances in Psychopharmacology|September 25, 2020
Clozapine prescribing in COVID-19 positive medical inpatients: a case seriesMatthew Butler, Felicity Bano, Marilia Calcia, et al.
IEEE Computer Graphics and Applications|March 17, 2021
The Next Billion Users of VisualizationAmit Jena, Matthew Butler, Tim Dwyer, et al.
Veterinary Journal (London, England : 1997)|June 2, 2022
The microvascular endothelial glycocalyx: An additional piece of the puzzle in veterinary medicineSara J Lawrence-Mills, David Hughes, Melanie J Hezzell, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|July 15, 2021
Functional Neurological Disorder After SARS-CoV-2 Vaccines: Two Case Reports and Discussion of Potential Public Health ImplicationsMatthew Butler, Jan Coebergh, Farinaz Safavi, et al.
Headache|April 5, 2021
Pharmacokinetics and safety of ubrogepant when coadministered with calcitonin gene-related peptide-targeted monoclonal antibody migraine preventives in participants with migraine: A randomized phase 1b drug-drug interaction studyAbhijeet Jakate, Andrew M Blumenfeld, Ramesh Boinpally, et al.
Headache|January 9, 2020
Long-Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52-Week Extension TrialJessica Ailani, Richard B Lipton, Susan Hutchinson, et al.
Frontiers in Psychiatry|February 19, 2021
Reduced Activity in an Inpatient Liaison Psychiatry Service During the First Wave of the COVID-19 Pandemic: Comparison With 2019 Data and Characterization of the SARS-CoV-2 Positive CohortMatthew Butler, Afraa Delvi, Fedza Mujic, et al.
Haematologica|September 28, 2019
Functional assessment of glucocerebrosidase modulator efficacy in primary patient-derived macrophages is essential for drug development and patient stratificationNatalie J Welsh, Christina A Gewinner, Kavita Mistry, et al.
Pageof 7